- 2020
-
Press releases - 12.05.2020
Blood Stem Cell Immune Memory: A New Research Avenue in COVID-19
Blood stem cells have a surprising ability. In addition to ensuring the continuous renewal of blood cells, they keep track of past infections so that faster and more effective immune responses can be triggered in the future.
-
Press releases - 27.04.2020
EpiCOV: Population Immune Status Data to Guide Public Decision-Making
Driven by Inserm and the Directorate for Research, Studies, Assessment and Statistics (DREES) of France’s Ministry of Solidarity and Health, in conjunction with their partners (National Institute of Statistics and Economic Studies [INSEE], Public Health Agency, National Center for Scientific Research [CNRS], National Institute for Demographic Studies [INED], Université Paris-Saclay), EpiCOV is a large-scale epidemiological study based on a major statistical survey. It is proposing global and scientifically reliable mapping of population immune status and dynamics across the French territory through the collection of biological samples paired with questionnaires.
-
Press releases - 27.04.2020
The StopCovid project-team and the ecosystem of contributors are working together to develop a mobile contact tracing app for France
Inria, ANSSI, Capgemini, Dassault Systèmes, Inserm, Lunabee Studio, Orange, Santé Publique France and Withings create the StopCovid project team in order to structure and strengthen their contribution to the government project to set up a mobile contact tracing application (StopCovid). The purpose of this project is to provide the French health authorities with a complementary digital tool to help manage the sanitary emergency against Covid-19.
-
Press releases - 24.04.2020
Malaria: Vaccine clinical trial for Pregnant Women yields promising results
Malaria infection during pregnancy represents a major public health problem in the regions endemic for the disease, substantially increasing the risks to mothers and their unborn children. For newborns, malaria is linked to low birth weight and an excess risk of mortality. To protect this population, a team of researchers is developing a vaccine at the French National Institute of Blood Transfusion (INTS).
-
What's on? - 24.04.2020
Malaria: Vaccine clinical trial for Pregnant Women yields promising results
Malaria infection during pregnancy represents a major public health problem in the regions endemic for the disease, substantially increasing the risks to mothers and their unborn children. For newborns, malaria is linked to low birth weight and an excess risk of mortality. To protect this population, a team of researchers from Inserm and Université de […]
-
Press releases - 22.04.2020
Inserm’s commitment to the fight against the Covid-19 pandemic
Inserm has played a leading role in the French and international research spheres, rallying its many experts in subjects related to fundamental research, therapeutic research, and modelling. Participating also in France’s solidarity effort, the Institute has taken action to distribute tens of thousands of masks, gloves, gowns, shoe covers and reagents to medical teams working in the nation’s hospitals.
-
Press releases - 10.04.2020
COVID-19 and Confinement: A Large-Scale French Survey of Social Challenges and Health
For a deeper insight into the social and epidemiological challenges posed by the exceptional prevention measures taken in response to the COVID-19 pandemic – particularly confinement – a multidisciplinary group of researchers has joined forces with Inserm and the Public Health Agency to launch a survey of around 200,000 participants from five major French cohorts.
-
Press releases - 10.04.2020
Inserm and the African Countries: Partners in Fighting COVID-19
Furthering scientific knowledge knows no frontiers. Therefore, Inserm would like to reaffirm that the countries of Africa are – more than ever – key scientific partners
-
Press releases - 06.04.2020
Electronic Death Certificates to Improve Accuracy of COVID-19 Mortality Figures
In order to obtain accurate mortality figures on the COVID-19 pandemic, the data provided by the various entities authorized to issue death certificates – health care establishments, community doctors, emergency medical service (SAMU), and care homes for the elderly – need to be collected quickly. The widespread deployment of electronic death certification made possible by Inserm through its CertDc application should enable rapid acquisition of the figures needed, in order to improve monitoring of the pandemic.
-
Press releases - 03.04.2020
Health and environmental crises: a CNRS- Inserm joint initiative
The CNRS and Inserm, in association with the CPU, INED, INRAE and IRD, under the umbrella of ATHENA and AVIESAN1, are joining forces to raise key scientific questions on health and environmental crises and combine the initiatives of the humanities, social sciences and public health research communities arising from the current COVID-19 crisis.